FindTrial
Sign In

Effect of Takra Basti and Erandmooladi Niruha Basti in Grahani (Irritable Bowel Syndrome)

A Comparative Evaluation of Takra Basti and Erandamooladi Niruha Basti in Grahani (Irritable Bowel Syndrome) - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110090
Enrollment
30
Registered
2026-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Sponsors

Dr Megha Raturi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling diagnostic criteria of Grahani (IBS) having symptoms like Muhur Baddha Drava Mala Pravritti, Muhur Muhur Mala Pravritti, Udara Shoola (abdominal pain), and sense of incomplete evacuation. Diagnosed cases of Irritable Bowel Syndrome (IBS) fit for Basti Karma will be included

Exclusion criteria

Exclusion criteria: Patients with complications (upadrava) of Grahani. Patients suffering from severe systemic diseases which may interfere with treatment. Patients not fit for Basti karma. Pregnant and lactating women. Patients suffering from colonic cancer, ulcerative colitis, Crohn s disease or other serious gastrointestinal disorders will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Change/improvement in Grahani/IBS symptom scores especially Muhur Badda Drava Mala Pravritti, Muhur Muhur Mala Pravritti, Udara Shoola/discomfort, and sense of incomplete evacuation.Timepoint: BT (0th day), AT1 (23rd day), AT2 (30th day)—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Megha Raturi

Himalayiya Ayurvedic PG Medical College

raturimegha8@gmail.com9690000927

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026